Research output: Contribution to Journal/Magazine › Journal article › peer-review
<mark>Journal publication date</mark> | 02/2011 |
---|---|
<mark>Journal</mark> | European Neuropsychopharmacology |
Issue number | 2 |
Volume | 21 |
Number of pages | 12 |
Pages (from-to) | 180-191 |
Publication Status | Published |
Early online date | 2/10/10 |
<mark>Original language</mark> | English |
We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.